FDA Inspection 990174 — Mylan Pharmaceuticals Inc.
The FDA completed an inspection of Mylan Pharmaceuticals Inc. on Oct 14, 2016 in San Carlos, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 14, 2016
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- San Carlos, CA (United States)